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Abstract 
We have reported here a series of ligands containing pentadentate 6,6′-(azanediylbis(methylene))dipicolinic 
acid units that differ in the substituent present at the amine nitrogen atom (acetate: H3DPAAA; phenyl: 
H2DPAPhA; dodecyl: H2DPAC12A; 4-hexylphenyl: H2DPAC6PhA). The protonation constants of the 
hexadentate DPAAA
3−
 and pentadentate DPAPhA
2−
ligands and the stability constants of their 
Mn
2+
 complexes were determined using pH-potentiometry (25 °C, 0.15 M NaCl). The mono-hydrated 
[Mn(DPAAA)]
−
 complex (log KMnL = 13.19(5)) was found to be considerably more stable than the bis-
hydrated [Mn(DPAPhA)] analogue (log KMnL = 9.55(1)). A detailed 
1
H and 
17
O NMR relaxometric study was 
carried out to determine the parameters that govern the proton relaxivities of these complexes. The 
[Mn(DPAC12A)] complex, which contains a dodecyl lipophilic chain, forms micelles in solution 
characterized by a critical micellar concentration (cmc) of 96(9) μM. The lipophilic [Mn(DPAC6PhA)] and 
[Mn(DPAC12A)] derivatives form rather strong adducts with Human Serum Albumin (HSA) with 
association constants of 7.1 ± 0.1 × 10
3
 and 1.3 ± 0.4 × 10
5
 M
−1
, respectively. The X-ray structure of the 
complex {K(H2O)4}{[Mn(DPAAA)(H2O)]}2 shows that the Mn
2+
 ion in [Mn(DPAAA)]
−
 is coordinated to 
the six donor atoms of the ligand, a coordinated water molecule completing the pentagonal bipyramidal 
coordination environment. 
Keywords: magnetic resonance imaging; manganese complexes; picolinate ligands; relaxivity; DFT 
calculations 
 
Introduction 
In recent years, the stable complexation of Mn
2+
 in aqueous solution has been attracting increasing attention 
due to the potential application of high-spin complexes of this metal ion as contrast enhancing agents in 
magnetic resonance imaging (MRI).
1,2
 Mn
2+
 salts were among the first compounds to be used as contrast 
 
 
agents to distinguish normal myocardial tissue from infarcted zones in animals.
3
 However, the advent of 
rather efficient Gd
3+
-based contrast agents (CA) developed during the 1980s and 1990s concentrated most of 
the research efforts of the MRI community on this class of agents.
4
 As a result, only one Mn
2+
CA has been 
approved for clinical use (mangafodipir trisodium, Na3[Mn(H3DPDP)], TESLASCAN®, Scheme 1).
5
 This 
hepatocyte specific MRI contrast agent releases Mn
2+
, which is sequestered by the liver, providing an 
enhanced contrast for diagnostic imaging.
6
 However, some toxicity problems associated with the 
administration of Gd
3+
-based MRI CAs
7
 have renewed the interest in Mn
2+
 agents,
8–10
 which are expected to 
have a better toxicity profile.
1
  
The design of Mn
2+
-based MRI contrast agents represents a challenge for coordination chemistry. Indeed, a 
Mn
2+
 complex should fulfil a number of requirements to become a potential CA candidate: (i) a high 
thermodynamic and kinetic stability to avoid the release of the toxic Mn
2+
 ions. The lack of a crystal field 
stabilization energy associated with the high-spin d
5
configuration results in rather low thermodynamic 
stabilities of Mn
2+
 complexes, which are also generally rather labile with respect to complex 
dissociation;
11
 (ii) the presence of at least one water molecule coordinated to the metal ion that exchanges 
rapidly with the bulk water, thereby imparting an efficient pathway to accelerate the relaxation rates of water 
proton nuclei. It is worth noting that Mn
2+
 chelates with high thermodynamic stability such as 
[Mn(DOTA)]
2−
 and [Mn(DO3A)]
−
 do not contain coordinated water molecules;
12
 (iii) a good redox stability 
to avoid the oxidation of Mn
2+
 to Mn
3+
, which generally provides lower relaxivities. However, redox 
Mn
2+
/Mn
3+
 potentials accessible to biologically relevant reducing agents can be potentially exploited to 
design redox-activated MRI probes.
13,14
 
 
 
Scheme 1. Structures of the ligands discussed in this work. 
 
 
In recent papers, we have reported the pentadentate ligand H2DPAMeA
15
 and derivatives bearing two or 
three H2DPAMeA binding motifs for the formation of bi- and tri-nuclear Mn
2+
 entities.
16
 These complexes 
contain two water molecules coordinated to the metal ions, which results in relatively high relaxivities. 
Furthermore, the observed 
1
H relaxivities increased considerably in plasma due to binding to human serum 
albumin (HSA). However, the Mn
2+
 complex formed by the H2BCPE ligand does not contain inner-sphere 
water molecules, which highlights the difficulty of predicting the hydration numbers for this family of 
complexes. Herein, we expand the family of ligands containing picolinate groups by reporting the 
pentadentate ligand H2DPAPhA and the hexadentate derivative H3DPAAA. The latter ligand was reported 
previously by Mazzanti and colleagues and investigated in the context of Gd
3+
 MRI CAs.
17
 Furthermore, we 
also report two lipophilic derivatives of H2DPAMeA and H2DPAPhA, which contain a dodecyl side chain 
attached to the amine nitrogen atom of H2DPAMeA or a hexyl chain at the aniline function of H2DPAPhA, 
respectively. These lipophilic derivatives were designed to form micelles in solution and to bind HSA in a 
non-covalent fashion. Both effects are expected to increase the observed relaxivity by slowing down the 
rotation of the complex in solution. We report the synthesis and acid–base properties of the ligands, the 
stability constants of the Mn
2+
 complexes in solution, and a full physicochemical characterization of the 
chelates using 
1
H and 
17
O relaxometric techniques and theoretical (DFT) calculations. 
 
Results and discussion 
Synthesis of the ligands 
The ligands reported in this work were prepared following the two-step procedure shown in Scheme 2. The 
first step consisted in the reaction of 6-chloromethylpyridine-2-carboxylic acid ethyl ester with an 
appropriate amine in the presence of K2CO3 as a base. It is worth mentioning that the reactions with anilines 
required rather harsh conditions involving heating for prolonged periods and the addition of catalytic KI. The 
ester intermediates were isolated in rather good yields (65–72%) after purification using column 
chromatography. Hydrolysis of the ethyl ester groups (and the amide group of the precursor of H3DPAAA) 
provided the target ligands as the hydrochloride salts in good overall yields (52–61%).  
 
 
Scheme 2. Synthesis of the ligands. 
 
 
Ligand protonation constants and stability constants of the Mn
2+
 complexes 
The protonation constants of DPAPhA
2−
 and DPAAA
3−
 were determined by potentiometric titrations in 0.15 
M NaCl. The ligand protonation constants are defined in eqn (1): 
 
  𝐾𝑖
H =
[H𝑖L]
[H𝑖−1L][H+]
 with 𝑖 = 1,2,3,4.    (1) 
 
The protonation constants together with their corresponding standard deviations are compiled in Table 1. 
 
Table 1. Ligand protonation constants and stability and protonation constants of the corresponding Mn
2+
 complexes 
determined using potentiometric titrations (25 °C, 0.15 M NaCl) 
 
  DPAAA
3−
 DPAPhA
2−
 DPAMeA
2− a
 EDTA
4− b
 
log K1
H 7.26(2) 5.48(4) 7.82 10.17 
log K2
H 3.90(3) 4.51(4) 3.71 6.11 
log K3
H 3.29(2) 4.28(4) 2.61 2.68 
log K4
H 1.77(2) 2.70(4)   
∑log Ki
H 16.22 16.97 14.14  
log KMnL 13.19(5) 9.55(1) 10.13 13.88 
log KMnLH 2.90(6) 4.84(1) 2.57  
log KMnLH2  2.51(1)   
log KMLOH 11.97(6)  11.09  
pMnc 8.98 7.27 7.28 7.95 
 
a 
Data from ref. 16. 
b
 Data from ref. 19. c Defined as −log[Mn]free with pH = 7.4, [Mn
2+
] = [L] = 10
–5
 M. 
 
 
Four protonation constants could be determined for DPAAA
3−
, indicating the stepwise protonation of the 
amine nitrogen atom and all three carboxylate groups of the ligand. The first and second protonation 
constants of DPAAA
3−
 are very similar to those reported previously for DPAMeA
2−
. These protonation 
processes are assigned to the protonation of the amine nitrogen atom (K1
H
) and one of the carboxylate groups 
of the picolinate arms (K2
H
). The first protonation constant of DPAPhA
2−
 (log K1
H
 = 5.48(4)) is ca. two 
orders of magnitude lower than those determined for DPAAA
3−
 and DPAMeA
2−
, in line with the lower 
basicity of anilines compared to aliphatic amines.
18
 Four protonation constants could be determined for 
DPAPhA
2−
, indicating the protonation of the aniline nitrogen atom, two carboxylate groups and likely a 
nitrogen atom of a pyridine moiety. As a result, the DPAAA
3−
 and DPAPhA
2−
 ligands present very similar 
overall basicities, as estimated by the ∑log Ki
H
 values (i = 1–4). The protonation constants determined for 
DPAAA
3−
 in 0.15 M NaCl are in good agreement with those reported by Mazzanti in 0.1 M KCl (log K1
H
 = 
7.33, log K2
H
 = 3.8 and log K3
H
 = 2.9).
17
 
The stability and protonation constants of the Mn
2+
 complexes of DPAAA
3−
 and DPAPhA
2−
 were determined 
using direct potentiometric pH-titrations. The stability constants and protonation constants of the complexes 
are defined in eqn (2) and (3): 
 
 
   𝐾ML =
[ML]
[M][L]
      (2) 
 
   𝐾H𝑖L =
[MH𝑖L]
[MH𝑖−1L][H+]
 with 𝑖 = 1, 2.   (3) 
 
The titration curve of the Mn
2+
:DPAAA
3−
 system evidenced the formation of a hydroxo complex 
characterized by the protonation constant KMLOH defined as: 
 
   𝐾MLOH =
[ML]
[ML(OH)][H+]
     (4) 
 
The stability constant of the [Mn(DPAPhA)] complex is slightly lower than that reported previously for 
[Mn(DPAMeA)], which is likely related to the weaker coordination of the aniline nitrogen atom of 
DPAPhA
2−
 compared to the amine nitrogen atom of DPAMeA
2−
 (see computational details below). The 
presence of an additional carboxylate group in DPAAA
3−
 increases the stability of the Mn
2+
 complex by 
three orders of magnitude with respect to DPAMeA
2−
. As a result, the stability constant of the 
[Mn(DPAAA)]
−
 complex (log KML = 13.19(5)) approaches that of the EDTA analogue (log KML = 13.88).
19
 
Fig. 1 presents the species distribution diagrams calculated using the equilibrium constants reported in Table 
1. The [Mn(DPAAA)]
−
 species is the most abundant one in a wide range of pH from ca. 2.8 to 11.4. The 
formation of the hydroxo [Mn(DPAAA)(OH)]
2−
 species occurs above pH ∼ 10, while the protonation of the 
complex is observed below pH ∼ 5.0. Dissociation of the complex takes place at a rather low pH, with only 
5.6% of the manganese in the form of [Mn(H2O)6]
2+
 at pH 2.0. 
The dissociation of [Mn(DPAPhA)] starts at higher pH than that of [Mn(DPAAA)]
−
, as 27.8% of the 
complex is dissociated at pH 2.0. However, the degree of dissociation of the complex at pH 2.0 is even 
higher in the case of [Mn(DPAMeA)] (77.7%).
16
[Mn(DPAPhA)] forms protonated species at rather high pH 
(<7.0). 
A comparison of the thermodynamic stabilities of complexes with different ligands is more appropriately 
given by the pMn values (pMn = −log[Mn2+]free) defined using the conditions suggested by Drahos
20
 (pH = 
7.4, [Mn
2+
] = [L] = 10
–5
 M). The pMn values calculated for [Mn(DPAMeA)] and [Mn(DPAPhA)] are 
virtually identical (7.3, Table 1) and somewhat lower than that of [Mn(EDTA)]
2−
. The latter complex serves 
as a reference for potential MRI applications, as [Mn(EDTA)]
2−
 derivatives have been successfully used in in 
vivo MRI studies.
21
 Interestingly, the [Mn(DPAAA)]
−
 complex presents a pMn value one order of magnitude 
higher than [Mn(EDTA)]
2−
 and very close to that reported for [Mn(DOTA)]
2−
,
22
 which highlights its 
remarkable thermodynamic stability at physiological pH. 
X-ray structure of (K(H2O)4){[Mn(DPAAA)(H2O)]}2 
Slow evaporation of an aqueous solution of the [Mn(DPAAA)]
−
 complex provided single crystals suitable 
for X-ray diffraction analysis. The crystals contain two [Mn(DPAAA)(H2O)]
−
 entities joined by a [K(H2O)3]
+
 
unit through two μ–η1-carboxylate units (bridging Mn1 and K1) and a μ2–η
1
:η1-carboxylate group (bridging 
Mn2 and K1).
23
 A second potassium ion required to maintain electroneutrality could not be unequivocally 
 
 
located (see the Experimental section for details). The metal ions in each [Mn(DPAAA)(H2O)]
−
 unit are 
directly coordinated to the amine nitrogen atom of the ligand, two pyridyl nitrogen atoms and two oxygen 
atoms of carboxylate groups, seven coordination being completed by the presence of a coordinated water 
molecule. The metal coordination environment in each [Mn(DPAAA)(H2O)]
−
 unit may be described as 
pentagonal bipyramidal, with the equatorial plane defined by the amine nitrogen atom and the four donor 
atoms of two picolinate units. An oxygen atom of the acetate pendant and a water molecule occupy the axial 
positions (Table 2). 
 
Table 2. Bond distances (Å) of the Mn
2+
 coordination environments in {K(H2O)4}{[Mn(DPAAA)(H2O)]}2
a 
 
Mn1–O1W 2.174(3) Mn2–O2W 2.267(4) 
Mn1–O3a 2.200(11) Mn2–O8 2.165(3) 
Mn1–N1 2.259(3) Mn2–N3 2.249(3) 
Mn1–O1 2.266(3) Mn2–O5 2.204(3) 
Mn1–N2 2.457(6) Mn2–N4 2.475(5) 
 
a
 See Fig. 2 for labelling. 
 
 
 
Fig. 1. Species distribution diagrams calculated for the H3DPAAA:Mn
2+
 (top) and H2DPAPhA:Mn
2+
 (bottom) systems. 
[L] = [Mn
2+
] = 10
–3
 M. 
 
 
The O3a–Mn1–O1w and O8–Mn2–O2w angles (156.7(3) and 166.11(19)°, respectively) deviate 
significantly from the expected values for a pentagonal bipyramidal coordination, reflecting rather distorted 
coordination polyhedra. The D1–Mn–D2 angles, where D1 and D2 represent adjacent donors of the 
equatorial plane, fall within the range 70.0–76.1°, and are therefore close to the value expected for 
pentagonal bipyramidal coordination (72°). 
The bond distances of the Mn
2+
 coordination environments involving equivalent oxygen donor atoms in the 
two [Mn(DPAAA)(H2O)]
−
 entities present significant differences. For instance, the Mn1–O1 distances 
[2.266(3) Å] are considerably longer than the Mn2-O5 ones [2.204(3) Å], probably as a result of the μ–
η1 coordination of the carboxylate group containing O1. However, the μ2–η
1
:η1 carboxylate coordination 
gives a short Mn2–O8 distance [2.165(3) Å] when compared to Mn–O3a [2.200(11) Å]. The shorter bond 
distance involving the carboxylate donor atom O8 results in a rather long trans Mn2–O2W bond [2.267(4) 
Å]. 
 
 
Fig. 2. View of the structure of the X-ray structure of {K(H2O)4}{[Mn(DPAAA)(H2O)]}2 
 
1
H NMRD and 
17
O NMR studies of the [Mn(DPAPhA)] and [Mn(DPAAA)]
−
 complexes 
Proton relaxivity, r1p, which is defined as the relaxation enhancement of water protons promoted by the 
paramagnetic agent at 1 mM concentration, provides a convenient assessment of the efficiency of a 
paramagnetic complex as a contrast agent in vitro. The relaxivity determined for [Mn(DPAAA)]
−
 at pH 7.4 
(25 °C, 20 MHz) is 3.6 mM
−1
 s
−1
, a value that is close to that reported for monohydrated complexes such as 
[Mn(EDTA)]
2−
 (3.3 mM
−1
 s
−1
 at pH 7.4, 25 °C and 20 MHz). The r1p value measured for [Mn(DPAPhA)] 
under the same conditions (6.7 mM
−1
 s
−1
) is considerably higher, which indicates the presence of two 
coordinated water molecules (Fig. 3).  
The relaxivity of [Mn(DPAAA)]
−
 remains fairly constant (r1p = 3.60 ± 0.15 mM
−1
 s
−1
 at 25 °C, 20 MHz) in a 
broad pH range from 2.5 to 11.5. Below pH 2.5, relaxivity increases due to the dissociation of the complex 
 
 
and the formation of [Mn(H2O)6]
2+
, while the slight decrease in relaxivity observed at pH > 11.5 is attributed 
to the formation of a hydroxo complex. Thus, the pH dependence of r1p is in perfect agreement with the 
speciation in solution obtained from potentiometric measurements (Fig. 1). 
The relaxivity of [Mn(DPAPhA)] does not change significantly in the pH range 5.9–10.2, dropping quickly 
at more basic pH due to the dissociation of the complex and precipitation of Mn(OH)2.
241
H relaxivity 
decreases from 6.7 at pH 5.9 to 6.1 at pH 3.3. This effect can be attributed to the formation of the protonated 
[Mn(HDPAPhA)]
+
 species (log KMnLH = 4.84(1), see above). Dissociation of the complex below pH ∼ 2.7 is 
responsible for the slight increase in relaxivity under acidic conditions. 
Proton nuclear magnetic relaxation dispersion (
1
H NMRD) profiles of aqueous solutions [Mn(DPAPhA)] 
and [Mn(DPAAA)]
−
 (Fig. 4) were recorded in the proton Larmor frequency range 0.01–70 MHz 
(corresponding to magnetic field strengths varying between 2.343 × 10
−4
 and 1.645 T). The relaxivities of 
both complexes decrease with increasing temperature, as expected for small chelates in which fast rotation in 
solution limits proton relaxivity. The NMRD profiles present a single dispersion in the range 1–10 MHz, 
which rules out a sizeable scalar contribution to 
1
H relaxivity.
25,26
 
 
 
Fig. 3. Plot of the 
1
H relaxivities (20 MHz, 25 °C) of [Mn(DPAPhA)] and [Mn(DPAAA)]
−
 as a function of pH. 
 
 
Fig. 4. 
1
H NMRD profiles recorded at different temperatures for [Mn(DPAAA)]
−
 and [Mn(DPAPhA)]. The lines 
represent the fit of the data as explained in the text. 
 
 
Reduced transverse 
17
O NMR relaxation rates of aqueous solutions of the [Mn(DPAPhA)] and 
[Mn(DPAAA)]
− 
complexes were recorded to gain more insight into the physicochemical parameters 
governing the relaxivities of these systems (Fig. 5). The 1/T2rvalues increase with decreasing temperature, 
reach a maximum and then decrease at lower temperatures. This is typical of systems that present a 
changeover from a fast exchange regime at high temperatures to a slow exchange at low temperatures.
27
 The 
lower temperature at which the maximum 1/T2r value is observed for [Mn(DPAAA)]
−
 (ca. 15 °C) compared 
with [Mn(DPAPhA)] (∼23 °C) is indicative of a somewhat faster water exchange rate in the former. 
 
 
Fig. 5. Reduced transverse 
17
O NMR relaxation rates versus reciprocal temperature measured for [Mn(DPAAA)]
−
 and 
[Mn(DPAPhA)] at 11.74 T. The lines represent the fit of the data as explained in the text. 
 
A simultaneous fitting of the 
1
H NMRD and 
17
O NMR data of [Mn(DPAPhA)] and [Mn(DPAAA)]
−
 was 
carried out using well-established procedures.
16
 Since the NMRD and 
17
O NMR data depend on a relatively 
large number of parameters some of them had to be fixed during the fitting procedure to achieve a reliable 
analysis. The distance of closest approach for the outer-sphere contribution aMnH was fixed at 3.6 Å, while 
the distances between the proton nuclei of the coordinated water molecules and the Mn
2+
 ion (rMnH) were 
fixed at values corresponding to the average Mn⋯H distances obtained from DFT calculations (2.756 and 
2.782 Å for [Mn(DPAAA)]
−
 and [Mn(DPAPhA)], respectively). The number of water molecules in the inner 
coordination sphere of Mn
2+
 was fixed at q = 2 for [Mn(DPAPhA)] and q = 1 for [Mn(DPAAA)]
−
. Finally, 
the diffusion coefficient, D
298
MnH, and its activation energy, EDMnH, were fixed at the values for self-diffusion 
of water molecules in pure water.
28
 The parameters obtained from the fittings are provided in Table 4, while 
the curve fits are shown in Fig. 4 and 5. 
The water exchange rate determined for [Mn(DPAAA)]
−
 (k
298
ex = 12.6 × 10
7
 s
−1
) is about two times that 
measured for [Mn(DPAPhA)] (k
298
ex = 5.6 × 10
7
 s
−1
). Both complexes present lower water exchange rates 
than [Mn(EDTA)]
2−
,
29
 approaching that determined for the aquated ion [Mn(H2O)6]
2+
 (k
298
ex = 2.8 × 
10
7
 s
−1
).
26
 DFT calculations performed in aqueous solution at the TPSSh/TZVP level provide some insight 
into the different water exchange rates determined for [Mn(DPAPhA)] and [Mn(DPAAA)]
−
(Fig. 6). In these 
calculations we included two second-sphere water molecules involved in hydrogen bonding with each 
coordinated water molecule, while bulk solvent effects were considered using a polarized continuum model 
(see Computational details below). This mixed cluster/continuum approach was shown to provide accurate 
Mn–Owater distances and 
1
H and 
17
O hyperfine coupling constants of the coordinated water molecules.
9,26
 The 
optimized geometries of the [Mn(DPAPhA)(H2O)2]·4H2O and [Mn(DPAAA)(H2O)]
−
·2H2O systems indicate 
pentagonal bipyramidal coordination environments around the Mn
2+
 ion. The equatorial plane of the 
bipyramid is delineated by the amine nitrogen atom and the donor atoms of the picolinate units. In the case 
 
 
of [Mn(DPAPhA)(H2O)2]·4H2O two coordinated water molecules occupy the apical positions, while for 
[Mn(DPAAA)(H2O)]
−
·2H2O the apical positions contain a coordinated water molecule and an oxygen atom 
of the acetate group of the ligand. 
 
 
Fig. 6. Structures of the [Mn(DPAAA)(H2O)]
−
·2H2O and [Mn(DPAPhA)(H2O)2]·4H2O systems obtained with DFT 
calculations (TPSSh/TZVP). Calculated bond distances (Å): [Mn(DPAAA)(H2O)]
−
·2H2O, Mn–N(1), 2.314; Mn–N(2), 
2.521; Mn–N(3), 2.316; Mn–O(1), 2.289; Mn–O(2), 2.291; Mn–O(1w), 2.288; Mn–O(3), 2.131. 
[Mn(DPAPhA)(H2O)2]·4H2O, Mn–N(1), 2.285; Mn–N(2), 2.885; Mn–N(3), 2.268; Mn–O(1), 2.225; Mn–O(2), 2.289; 
Mn–O(1w), 2.250; Mn–O(4w), 2.237. 
 
The calculated Mn–Owater distances involving the coordinated water molecule(s) are 2.288 Å for 
[Mn(DPAAA)(H2O)]
−
·2H2O and 2.237 and 2.250 Å for [Mn(DPAPhA)(H2O)2]·4H2O. Thus, the Mn–Owater 
distance in [Mn(DPAAA)(H2O)]
−
 is significantly longer than those of the complex with DPAPhA
2−
, 
revealing weaker binding of the coordinated water molecule in the former. Water exchange in these seven-
coordinated complexes is expected to follow a dissociatively activated mechanism, the rate determining step 
being the rupture of the Mn–Owater bond to give a six-coordinated transition state. Thus, the stronger the Mn–
Owater bond, the slower the water exchange process is expected to be. Similar trends correlating the strength 
of the Gd–Owaterbonds and the corresponding water exchange rates were observed for nine-coordinate 
Gd
3+
 complexes undergoing dissociatively activated water exchange processes.
30
 
The values obtained for the 
17
O hyperfine coupling constants are in the lower part of the range typically 
observed for Mn
2+
complexes (AO/ħ = 25 × 10
6
 to 47 × 10
6
 rad s
−1
), being very similar to the values reported 
for [Mn(H2O)6]
2+
 and other small complexes.
31
 Concerning the parameters related to the electron spin 
relaxation of the metal ion (the electronic correlation time for the modulation of the zero-field-splitting 
interaction, τV, and the mean square zero-field-splitting energy, Δ
2
), the parameters obtained from the 
analysis of NMRD and 
17
O NMR data are similar to those obtained for other Mn
2+
 complexes (Table 3). 
Characterization of the lipophilic derivatives [Mn(DPAC6PhA)] and [Mn(DPAC12A)] 
The critical micelle concentration (cmc) of [Mn(DPAC6PhA)] and [Mn(DPAC12A)] was investigated by 
using relaxometric measurements at 20 MHz and 25 °C.
32
 The paramagnetic relaxation enhancement of 
water proton nuclei (R
obs
1) increased linearly with the concentration of the [Mn(DPAC6PhA)] complex in the 
range 0.07–0.61 mM (Fig. S17, ESI†). The slope of the linear plot provides a relaxivity of the non-
 
 
aggregated form of 4.1 mM
−1
 s
−1
. This value is consistent with that obtained from NMRD studies, which 
confirms the lack of self-aggregation of the complex under these conditions (Fig. S18, ESI†). Precipitation of 
the complex was observed at higher concentrations, thus preventing cmc determination. Surprisingly, the 
relaxivity determined for [Mn(DPAC6PhA)] is considerably lower than that of the bis-hydrated 
[Mn(DPAPhA)] complex (6.6 mM
−1
 s
−1
), which suggests that the introduction of the hexyl chain into the 
ligand scaffold lowers the hydration number of the complex. 
 
Table 3. Parameters obtained from the simultaneous analysis of 
17
O NMR and 
1
H NMRD data
a
 
  [Mn(DPAAA)]
−
 [Mn(DPAPhA)] [Mn(DPAMeA)]
b
 [Mn(EDTA)]
2− c
 [Mn(H2O)6]
2+ d
 
r 1p at 25/37 °C/mM
−1
 s
−1b
 3.5/2.7 6.6/5.1 5.3/4.2 3.3/2.8  
k 
298
ex/10
7
 s
−1
 12.6 ± 0.5 5.6 ± 0.6 30.6 47.1 2.82 
ΔH‡/kJ mol−1 42.7 ± 1.0 27.2 ± 2.3 28.1 33.5 45.6 
τ 298R/ps 47.6 ± 0.2 81.0 ± 0.5 47.8 57 30.0 
E r/kJ mol
−1
 22.8 ± 0.4 27.0 ± 2.6 25.3 21.8 16.7 
τ 298V/ps 19.4 ± 0.2 15.6 ± 0.1 39.2 27.9 10.0 
E v/kJ mol
−1
 1.0
a
 1.0
a
 1.0
a
 1.0
a
 14.6 
D 
298
MnH/10
−10
m
2
 s
−1
 22.4
a
 22.4
a
 22.4
a
 23.1 23.0
a
 
E DMnH/kJ mol
−1
 17.3
a
 17.3
a
 17.3
a
 18.9 29.7 
Δ 2/1019 s−2 5.5 ± 0.2 11.5 ± 0.4 2.38 6.9 0.6 
A O/ħ/10
6
 rad s
−1
 –31.5 ± 0.6 –25.0 ± 0.6 –45.8 –40.5 –34.6 
r MnH/Å 2.756
a
 2.782
a
 2.74
a
 2.83
a
 2.83 
a MnH/Å 3.6
a
 3.6
a
 3.6
a
 3.6
a
 3.6 
q 
298
 1
a
 2
a
 2
a
 1
a
 6 
 
a 
Parameters fixed during the fitting procedure. 
b
 Data from ref. 16. 
c
 Data from ref. 29. 
d
 Data from ref. 26. 
 
 
The R
obs
1 values measured from solutions of [Mn(DPAC12A)] present two linear ranges with an inflection 
point at a complex concentration of ∼0.1 mM (Fig. S19, ESI†). The analysis of the data provides a cmc of 
96(9) μM with relaxivity values of r1p = 5.3 mM
−1
 s
−1
 and r1p = 8.5 mM
−1
 s
−1
 for the non-aggregated and 
aggregated forms, respectively. The cmc determined for [Mn(DPAC12A)] is similar to that reported for a 
charge neutral Eu
3+
 complex having a C12 alkyl chain (67 μM),
33
 but considerably lower than that determined 
for a similar system having negatively charged hydrophilic head units (4.5 mM).
34
 These results suggest that 
repulsive electrostatic interactions among the negatively charged head units are detrimental to the formation 
of micelles. 
The relaxivity of [Mn(DPAC12A)] below the cmc (r1p = 5.3 mM
−1
 s
−1
) is lower than that of 
[Mn(DPAMeA)], which suggests that the incorporation of the C12 alkyl chains into the ligand skeleton 
lowers the hydration number of the complex. As expected, the NMRD profile recorded below the cmc is 
typical of a small Mn
2+
 complex (Fig. 7). The best-fit analysis confirms these qualitative observations. The 
NMRD profile below cmc is well reproduced by fixing at one the number of inner-sphere water molecules, 
at a distance of 2.782 Å and with a residence lifetime of 10 ns (298 K). The relaxivity is limited by the 
rotational dynamics even though the parameter τR assumes a value of 123 ps, more than two times that of 
[Mn(EDTA)]
−
 and [Mn(DPAAA)]
−
. The longer τRreflects the presence of the pendant aliphatic chain and its 
effect is apparent from the nearly vanished field-dependence of relaxivity at high frequencies. The electronic 
relaxation parameters assume typical values: τV = 21.4 ps and Δ
2
 = 8.1 × 10
19
 s
−2
. Conversely, above the cmc 
the NMRD profile presents a pronounced peak around 30 MHz that is characteristic of slowly tumbling 
 
 
systems. The NMRD at high field (>3 MHz) was fitted using the Lipari–Szabo approach, which separates the 
global and local motions of the system.
35
 The analysis was performed by using as adjustable parameters 
those describing electron spin relaxation (τv and Δ
2
), the correlation times describing global (τRG) and local 
(τRL) motions and the generalized order parameter S
2
, which takes a value of 0 if the internal motion is 
isotropic and a value of S
2
 = 1 if the motion is completely restricted. The hydration number was fixed at q = 
1, while the Mn⋯H distance (2.74 Å), the distance of closest approach of a second-sphere water molecule 
(aMnH = 3.6 Å) and the diffusion coefficient (D
298
MnH = 2.24 × 10
−10
 m
2
 s
−1
) were fixed at reasonable values 
(Table 3). The results of the fit provided τRG = 5 ns and τRL = 95 ps, with S
2
 = 0.27, indicating that relaxivity 
is limited by local rotational flexibility (Table 4).
36
 Analysis of the NMRD profile recorded at 37 °C provides 
very similar results (Fig. S20, ESI†). 1H relaxivity decreases with increasing temperature, which indicates 
that the exchange rate of the coordinated water molecule is not limiting r1p. 
 
Table 4. Selected parameters obtained from the analysis of the NMRD profiles using  
the Lipari–Szabo approach (25 °C) 
 
  Mn(DPAC12A)
a
 Mn(DPAC12A) + HSA
b
 Mn(DPAC6PhA) + HSA
c
 
r 1p (20 MHz) 8.5 ± 0.1 15.5 ± 0.3 45.5 ± 1.4 
τ RG (ns) 5.5 ± 0.7 50 (fixed) 50 (fixed) 
τ RL (ps) 91 ± 3 306 ± 10 1235 ± 52 
S 
2
 0.27 ± 0.01 0.26 ± 0.01 0.43 ± 0.02 
K A/M
−1
 — 1.3 ± 0.4 × 105 7.1 ± 0.1 × 103 
 
a τ v = 49 ± 8 ps; Δ
2
 = 5.4 ± 0.6 s
−2
. 
b τ v = 22 ± 9 ps; Δ
2
 = 1.0 ± 0.6 s
−2
. 
c
 τ v = 18 ± 8 ps; Δ
2
 = 0.84 ± 0.04 s
−2
. 
 
 
 
Fig. 7. 
1
H NMRD profiles recorded at 25 °C for [Mn(DPAC12A)] above and below the cmc. The red lines represent the 
fit of the data as described in the text. 
 
Interaction of the lipophilic derivatives [Mn(DPAC6PhA)] and [Mn(DPAC12A)] with HSA 
The interaction of [Mn(DPAC6PhA)] and [Mn(DPAC12A)] with HSA was investigated by measuring 
the R
obs
1 values of a diluted solution of the complex as a function of protein concentration at a fixed 
frequency and temperature. R
obs
1 increases with the concentration of the protein because of the increase in the 
fraction of bound complexes that is characterized by a slower reorientational motion. The analysis of the 
 
 
titration data (fitted to a 1 : 1 binding isotherm) affords the association constant KA, the number of equivalent 
and independent binding sites n (assumed to be 1) and the relaxivity of the bound form. The titration profile 
obtained for [Mn(DPAC6PhA)] presents a rather sharp inflection point, which is indicative of a rather high 
stability constant (Fig. 8). On the contrary, [Mn(DPAC12A)] provides a smooth titration profile, 
characteristic of a smaller association constant. Inspection of the titration profiles also shows that the 
relaxivity of the bound form is considerably higher in the case of [Mn(DPAC6PhA)]. The fit of the data 
confirms these qualitative observations (Table 4). The association constant determined for [Mn(DPAC12A)] 
(1.3 × 10
5
 M
−1
) is 1–2 orders of magnitude higher than those determined for Mn2+ complexes containing 
benzyloxymethyl groups,
37
 and ca. 18 times higher than that obtained for [Mn(DPAC6PhA)]. These results 
suggest that a lipophilic C12 alkyl chain provides a stronger interaction with the protein than 
benzyloxymethyl and 4-hexylphenyl moieties. This could be related to a better ability to penetrate inside the 
hydrophobic binding cavity of HSA.
38
  
 
 
Fig. 8. Changes in the observed longitudinal relaxation rates of water protons observed upon the addition of HSA to 
solutions of the lipophilic [Mn(DPAC6PhA)] (0.094 mM) and [Mn(DPAC12A)] (0.098 mM) complexes (25 °C). The 
red lines represent the fit of the data to a 1 : 1 binding isotherm. 
 
 
 
Fig. 9. 
1
H NMRD profiles obtained at 25 °C for the adducts formed by [Mn(DPAC12A)] and [Mn(DPAC6PhA)] with 
HSA. The red lines represent the fit of the data above cmc using the Lipari–Szabo approach. 
 
 
 
The NMRD profiles recorded for the [Mn(DPAC6PhA)] and [Mn(DPAC12A)] complexes fully bound to 
HSA (Fig. 9) are characteristic of slowly tumbling species. The relaxivity of [Mn(DPAC6PhA)] at ca. 20 
MHz and 25 °C (45.5 mM
−1
 s
−1
) is close to those observed for HSA adducts of Mn
2+
 complexes containing 
benzyloxymethyl groups, while the relaxivity of [Mn(DPAC12A)] under the same conditions is clearly lower 
(15.5 mM
−1
 s
−1
). The analyses of the NMRD profiles using the Lipari–Szabo model (Table 4) clearly indicate 
that an increased local flexibility is responsible for the lower relaxivity of the adduct formed between 
[Mn(DPAC12A)] and HSA, as demonstrated by the lower values of τRL and S
2
. Thus, the alkyl C12 chain 
provides strong interactions with the protein, but its flexibility prevents attaining high relaxivities. 
 
Conclusions 
We have designed a series of pentadentate or hexadentate ligands that contain a pentadentate 6,6′-
(azanediylbis(methylene))dipicolinic acid binding motif that can be easily functionalised with groups 
containing additional donor atoms or lipophilic chains. The syntheses of the ligands followed a 
straightforward approach that allowed developing the versatile family of picolinate ligands for 
Mn
2+
 complexation. 
The pentadentate DPAPhA
2−
 and DPAMeA
2−
 ligands give rise to bis-aquated Mn
2+
 complexes in solution. 
The high hydration state of these complexes is associated with enhanced relaxivity values, fully comparable 
with those measured for q = 2 Gd
3+
complexes such as GdDO3A and GdPCTA.
4
 Clearly, the higher magnetic 
moment of Gd
3+
 is offset by the shorter Mn–Hw distance of the bound water molecule(s). Therefore, as 
regards the efficiency as relaxation agents, the Mn
2+
 complexes with picolinate ligands are virtually 
equivalent to the Gd
3+
 chelates. The functionalized derivatives with lipophilic chains can self-aggregate to 
form micelles. They are also able to form rather stable adducts with HSA, particularly when incorporating a 
flexible dodecyl chain. However, the relaxivity of the bound form is partially quenched due to the 
contribution of local motions arising from the rotational flexibility of the binding unit. An intriguing result 
obtained in this study is the likely reduction of the hydration number upon incorporating aliphatic chains into 
the ligand scaffold. 
The present contribution extends the number of Mn
2+
 systems that have been characterised in the context of 
MRI contrast agents as an alternative to the classical Gd
3+
 complexes. We have shown that the relaxivities of 
Mn
2+
 complexes can be modulated by changing the hydration number or by introducing lipophilic units into 
the ligand scaffold, very much like what is observed in the case of Gd
3+
 complexes. The relaxivities of the 
adducts formed with HSA are also comparable to those attained with lipophilic Gd
3+
 agents. However, the 
Mn
2+
 complexes with the pentadentate ligands lack sufficient stability for use in vivo. These results confirm 
the difficulty of developing Mn-based q = 2 complexes with a sufficient stability and kinetic inertness to be 
employed in clinical diagnostics. 
On the other hand, the hexadentate ligand DPAAA
3−
 forms with Mn
2+
 a complex with stability and relaxivity 
quite comparable to those of [Mn(EDTA)]
2−
. Of particular interest is the remarkable thermodynamic stability 
of [Mn(DPAAA)]
−
 at physiological pH, evidenced by the pM value of 8.98, similar to that of 
[Mn(DOTA)]
2−
 (Scheme 1). This complex has a relaxivity significantly greater than that of [Mn(1,4-DO2A)] 
as the latter shows in solution a small population (10%) of a six-coordinate isomeric form (q = 
0).
29
Moreover, when compared with the q = 1 [Mn(NOMPA)]
+
 complex, it shows a similar relaxivity but a 
stability constant increased by almost 3 log K units.
9a
 
Despite these interesting and encouraging results, there is still a need to expand the available library of Mn-
based chelates so far investigated to achieve better and more reliable information on the correlation between 
solution structure and molecular relaxation parameters. Moreover, it is very important to obtain accurate 
 
 
information relating to the thermodynamic stability and kinetic inertness of the complexes. This is key to 
develop safer probes with enhanced efficacy (relaxivity) for in vivo use. 
 
Experimental section 
Materials and methods 
All reagents and solvents were commercially available and used without further purification. SiO2 (Fluka, 
pore size 60 Å, 70–230 mesh) was used for preparative column chromatography. 1H and 13C NMR spectra 
were recorded at 25 °C on Bruker Avance 300 MHz and Bruker Avance 500 MHz spectrometers. High 
resolution ESI-TOF mass spectra were recorded using a LC-Q-q-TOF (Applied Biosystems QSTAR Elite) 
spectrometer in the positive mode. Elemental analyses were carried out using a ThermoQuest Flash EA 1112 
elemental analyser. IR spectra were recorded using a Bruker Vector 22 spectrophotometer equipped with a 
Golden Gate attenuated total reflectance (ATR) accessory (Specac). 
Synthesis of 6,6′-((dodecylazanediyl)bis(methylene))dipicolinic acid (H2DPAC12A) 
6-Chloromethylpyridine-2-carboxylic acid ethyl ester (1.18 g, 5.91 mmol) and K2CO3 (1.25 g, 9.05 mmol) 
were added to a solution of dodecylamine (0.51 g, 2.75 mmol) in 50 mL of acetonitrile. The mixture was 
stirred for a period of 3 days at room temperature and, after this, heated to 60 °C for 4 days. The excess 
K2CO3 was filtered off, the filtrate was concentrated to dryness, and the yellow residue was extracted with 50 
mL of a H2O and CHCl3 (1 : 3) mixture. The organic phase was evaporated to dryness to give an oily residue 
that was purified by column chromatography on SiO2 with a CHCl3/MeOH 2% mixture as the eluent to give 
the ester precursor (0.984 g, 1.92 mmol) as a yellow oil in 70% yield. 
1
H NMR (CDCl3, 300 MHz, 25 °C, 
TMS): δ 7.96 (m, 2H), 7.79 (m, 4H), 4.45 (c, 4H, 3J = 7.2 Hz), 3.92 (s, 4H), 2.54 (m, 2H), 1.52 (m, 2H), 1.42 
(t, 6H, 
3
J = 7.2 Hz), 1.22 (m, 17H), 0.87 ppm (m, 4H). 
13
C NMR (CDCl3, 75 MHz, 25 °C, TMS): δ 166.3, 
160.9, 147.6, 137.1, 125.6, 123.3, 61.8, 60.3, 54.7, 31.9, 29.6 (4 C), 29.5, 29.3, 27.3, 27.2, 22.7, 14.3, 14.1 
ppm. ESI
+
/HR-MS (CH3CN): m/z 512.3478; calcd for [C30H46N3O4]
+
 512.3482. IR (ATR): ν 1741 and 1716 
cm
−1
 (C O). 
A solution of ester precursor (0.984 g, 1.92 mmol) in 6 M HCl (20 mL) was heated to reflux for 3 h, 
resulting in the precipitation of an abundant white solid. It was collected by filtration and dried in vacuo to 
give H2DPAC12A (0.803 g) in 85% yield. 
1
H NMR (D2O, pD 7.0, 500 MHz, 25 °C, TMS): δ 7.62 (m, 4H), 
7.26 (m, 2H), 4.29 (m, 4H), 2.95 (m, 2H), 1.59–0.74 ppm (m, 23H). 13C NMR (D2O, pD 7.0, 125.8 MHz, 25 
°C, TMS): δ 171.2, 153.2, 151.6, 138.2, 125.5, 123.5, 58.7, 55.6, 31.9, 29.8, 29.7, 29.6, 29.5, 29.4, 29.1, 
26.7, 24.2, 22.6, 13.9 ppm. ESI
+
/MS (CH3CN): m/z 456 ([C26H38N3O4]
+
). IR (ATR): ν 1733 cm−1 (C O). 
Anal. calcd for C26H37N3O4·HCl: C, 63.46; H, 7.78; N, 8.54. Found: C, 63.40; H, 7.52; N, 8.23%. 
Synthesis of 6,6′-(((carboxymethyl)azanediyl)bis(methylene))dipicolinic acid (H3DPAAA) 
6-Chloromethylpyridine-2-carboxylic acid ethyl ester (1.18 g, 5.91 mmol) and K2CO3 (1.64 g, 11.8 mmol) 
were added to a solution of glycinamide hydrochloride (0.304 g, 2.75 mmol) in 50 mL of acetonitrile. The 
mixture was stirred for a period of 3 days at room temperature and, after this, heated to 60 °C for 4 days. The 
excess K2CO3 was filtered off, the filtrate was concentrated to dryness, and the yellow residue was extracted 
with 50 mL of a H2O and CHCl3 (1 : 3) mixture. The organic phase was evaporated to dryness to give an oily 
residue that was purified by column chromatography on SiO2 with a CHCl3/MeOH 5% mixture as the eluent 
to give the ester precursor (0.750 g, 1.87 mmol) as a pale yellow oil in 68% yield. 
1
H NMR (CDCl3, 300 
MHz, 25 °C, TMS): δ 9.40 (s, 1H), 7.79 (m, 4H), 7.98 (d, 2H, 3J = 7.7 Hz), 7.74 (t, 2H, 3J = 7.7 Hz), 7.53 (d, 
2H, 
3
J = 7.7 Hz), 5.67 (s, 1H), 4.46 (c, 4H, 
3
J = 7.2 Hz), 4.00 (s, 4H), 3.38 (s, 2H), 1.44 ppm (t, 6H, 
3
J = 7.2 
Hz). 
13
C NMR (CDCl3, 75 MHz, 25 °C, TMS):δ 174.6, 165.0, 158.9, 147.7, 137.5, 126.3, 123.7, 61.8, 60.0, 
 
 
58.4, 14.3 ppm. ESI
+
/HR-MS (CH3CN): m/z 401.1825; calcd for [C20H25N4O5]
+
 401.1819. IR (ATR): ν 1716 
and 1673 cm
−1
 (C O). 
A solution of the ester precursor (0.750 g, 1.87 mmol) in 6 M HCl (20 mL) was heated to reflux for 6 h, and 
then the solvent was removed using a rotary evaporator to give a yellow oil. A small amount of H2O was 
added (∼20 mL) and the mixture was evaporated to dryness. This process was repeated twice with addition 
of H2O and twice with addition of diethyl ether (∼20 mL) to give H3DPAAA (0.675 g) as a pale yellow solid 
in 83% yield. 
1
H NMR (D2O, pD 7.0, 500 MHz, 25 °C, TMS): δ 7.67 (t, 2H, 
3
J = 7.7 Hz), 7.63 (d, 2H, 
3
J = 
7.7 Hz), 7.34 (d, 2H, 
3
J = 7.7 Hz), 4.25 (s, 4H), 3.61 ppm (m, 2H). 
13
C NMR (D2O, pD 7.0, 125.8 MHz, 25 
°C, TMS): δ 174.5, 172.2, 153.1, 152.6, 138.5, 126.3, 123.1, 59.6, 58.6 ppm. ESI+/MS (CH3CN): m/z 346 
([C16H16N3O6]
+
). IR (ATR): ν 1769 and 1749 cm−1 (C O). Anal. calcd for C16H15N3O6·2HCl·H2O: C, 44.05; 
H, 4.39; N, 9.63. Found: C, 44.29; H, 4.25; N, 9.73%. 
Synthesis of 6,6′-((phenylazanediyl)bis(methylene))dipicolinic acid (H2DPAPhA) 
6-Chloromethylpyridine-2-carboxylic acid ethyl ester (1.97 g, 9.86 mmol) and K2CO3 (2.08 g, 15.1 mmol) 
were added to a solution of aniline (0.424 g, 4.55 mmol). The mixture was heated to 60 °C for 5 days and 
after this a catalytic amount of KI was added and the mixture was refluxed for a period of 2 days. The excess 
K2CO3 was filtered off, the filtrate was concentrated to dryness, and the yellow residue was extracted with 50 
mL of a H2O and CHCl3 (1 : 3) mixture. The organic phase was evaporated to dryness to give an oily residue 
that was purified by column chromatography on SiO2 with a CHCl3/MeOH 2% mixture as the eluent to give 
the ester precursor (1.24 g, 2.95 mmol) as a yellow oil in 65% yield. 
1
H NMR (CDCl3, 300 MHz, 25 °C, 
TMS): δ 8.01 (d, 2H, 3J = 7.7 Hz), 7.78 (t, 2H, 3J = 7.7 Hz), 7.46 (d, 2H, 3J = 7.7 Hz), 7.18 (m, 2H), 6.72 (m, 
3H), 4.94 (s, 4H), 4.49 (c, 4H, 
3
J = 7.2 Hz), 1.44 ppm (t, 6H, 
3
J = 7.2 Hz). 
13
C NMR (CDCl3, 75 MHz, 25 °C, 
TMS): δ 165.1, 159.5, 148.4, 148.0, 137.8, 129.4, 123.8, 123.5, 117.6, 112.4, 61.9, 51.2, 14.3 ppm. ESI+/HR-
MS (CH3CN): m/z 420.1918; calcd for [C24H26N3O4]
+
 420.1917. IR (ATR): ν 1716 cm−1 (C O). 
A solution of ester precursor (1.24 g, 2.95 mmol) in 6 M HCl (20 mL) was heated to reflux for 24 h, and then 
the solvent was removed in a rotary evaporator to give a brown oil. A small amount of H2O was added (∼20 
mL) and the mixture evaporated to dryness. This process was repeated twice with addition of H2O and twice 
with addition of diethyl ether (∼20 mL) to give H2DPAPhA (1.24 g) as a dark brown solid in 80% yield. 
1
H 
NMR (D2O, pD 7.0, 300 MHz, 25 °C, TMS): δ 7.70 (m, 4H), 7.30 (d, 2H, 
3
J= 6.9 Hz), 7.09 (m, 2H), 6.65 
(m, 3H), 4.82 ppm (s, 4H). 
13
C NMR (D2O, pD 7.0, 75 MHz, 25 °C, TMS): δ 172.9, 158.3, 153.4, 147.7, 
129.6, 122.9, 122.1, 117.5, 114.4, 112.9, 56.6 ppm. ESI
+
/MS (CH3CN): m/z 364 ([C20H18N3O4]
+
). IR 
(ATR): ν 1731 cm−1 (C O). Anal. calcd for C20H17N3O4·4HCl·H2O: C, 45.56; H, 4.40; N, 7.07. Found: C, 
46.02; H, 4.50; N, 7.04%. 
Synthesis of 6,6′-(((4-hexylphenyl)azanediyl)bis(methylene))dipicolinic acid (H2DPAC6PhA) 
6-Chloromethylpyridine-2-carboxylic acid ethyl ester (2.03 g, 10.2 mmol) and K2CO3 (2.14 g, 15.5 mmol) 
were added to a solution of 4-hexylaniline (0.833 g, 4.70 mmol). The mixture was heated to 60 °C for 5 days 
and after this a catalytic amount of KI was added and the mixture was refluxed for a period of 2 days. The 
excess K2CO3 was filtered off, the filtrate was concentrated to dryness, and the yellow residue was extracted 
with 50 mL of a H2O and CHCl3 (1 : 3) mixture. The organic phase was evaporated to dryness to give an oily 
residue that was purified by column chromatography on SiO2 with a CHCl3/MeOH 2% mixture as the eluent 
to give the ester precursor (1.70 g, 3.38 mmol) as a yellow oil in 72% yield. 
1
H NMR (CDCl3, 500 MHz, 25 
°C, TMS): δ 8.00 (d, 2H, 3J = 7.8 Hz), 7.77 (t, 2H, 3J = 7.8 Hz), 7.47 (d, 2H, 3J = 7.8 Hz), 6.99 (d, 2H, 3J = 
8.7 Hz), 6.61 (d, 2H, 
3
J = 8.7 Hz), 4.91 (s, 4H), 4.49 (c, 4H, 
3
J = 7.2 Hz), 2.47 (m, 2H), 1.54 (m, 2H), 1.44 (t, 
6H, 
3
J = 7.2 Hz), 1.28 (m, 6H), 0.87 ppm (m, 3H). 
13
C NMR (CDCl3, 125.5 MHz, 25 °C, TMS): δ 165.1, 
159.8, 148.3, 145.8, 137.8, 132.1, 129.3, 123.9, 123.5, 112.4, 61.9, 57.3, 34.8, 31.7, 31.6, 29.0, 22.6, 14.3, 
 
 
14.1 ppm. ESI
+
/HR-MS (CH3CN): m/z 504.2861; calcd for [C30H38N3O4]
+
 504.2856. IR (ATR): ν 1738 and 
1717 cm
−1
 (C O). 
A solution of the ester precursor (1.70 g, 3.38 mmol) in 6 M HCl (20 mL) was heated to reflux for 24 h, and 
then the solvent was removed in a rotary evaporator to give a yellow oil. A small amount of H2O was added 
(∼20 mL) and the mixture evaporated to dryness. This process was repeated twice with addition of H2O and 
twice with addition of diethyl ether (∼20 mL) to give H2DPAC6PhA (1.96 g) as a pale brown solid in 85% 
yield. 
1
H NMR (D2O, pD 7.0, 500 MHz, 25 °C, TMS): δ 7.47 (m, 2H), 7.05 (m, 2H), 6.74 (m, 2H), 6.48 (m, 
2H), 6.27 (m, 2H), 4.56 (s, 4H), 2.06 (m, 2H), 1.16–0.90 (m, 8H), 0.56 ppm (m, 3H). 13C NMR (D2O, pD 
7.0, 125.8 MHz, 25 °C, TMS): δ 171.3, 157.8, 152.7, 145.7, 138.4, 131.0, 129.0, 122.4, 112.5, 56.1, 34.5, 
31.5, 31.3, 28.9, 22.4, 13.7 ppm. ESI
+
/MS (CH3CN): m/z 448 ([C26H30N3O4]
+
). IR (ATR): ν 1682 cm−1 (C
O). Anal. calcd for C26H29N3O4·6HCl·H2O: C, 45.63; H, 5.45; N, 6.14. Found: C, 45.65; H, 5.43; N, 5.75%. 
Equilibrium measurements 
All the equilibrium measurements were conducted at a constant ionic strength maintained by 0.15 M NaCl at 
298 K. The protonation constants of the DPAAA
3−
 and DPAPhA
2−
 ligands were determined by pH-
potentiometric titrations using 0.002 M ligand solutions (8 mL) and a standardised 0.2 M NaOH solution as 
the titrant. The stability and protonation constants of Mn
2+
complexes were also determined by pH-
potentiometric titrations using 1 : 1 metal to ligand concentration ratios. Equilibrium constants were 
calculated using base mL–pH data pairs obtained in the pH range 1.7–12.0. The pH-potentiometric titrations 
were carried out using a 785 DMP Titrino titration workstation equipped with a Metrohm-6.0233.100 
combined electrode. The samples were stirred during the titrations while N2 gas was bubbled through the 
solutions to avoid CO2. For the calibration of the pH meter, KH-phthalate (pH = 4.002) and borax (pH = 
8.970) buffers were used. The H
+
 concentration was obtained from the measured pH values using the method 
proposed by Irving et al.
39
 A 0.01 M HCl (0.15 M NaCl) solution was titrated with 0.2 M NaOH and the 
differences between the measured and calculated pH values were used to calculate [H
+
] from the pH values 
determined in the titration experiments. Equilibrium constants were calculated with the PSEQUAD 
program.
40
 
1
H NMRD and 
17
O NMR measurements 
The Mn
2+
 complexes have been prepared by mixing solutions of MnCl2 and the ligand (in ca. 5% molar 
excess) and adjusting the pH to 7.4 with HCl or NaOH. The exact concentration of the aqueous solutions 
for 
1
H NMRD and 
17
O NMR measurements was determined by the BMS shift method at 11.7 T.
41
 The proton 
1/T1 NMRD profiles were measured using a fast field-cycling Stelar SmartTracer relaxometer (Mede, Pv, 
Italy) over a continuum of magnetic field strengths from 0.00024 to 0.25 T (corresponding to 0.01–10 MHz 
proton Larmor frequencies). The relaxometer was operated under computer control with an absolute 
uncertainty in 1/T1 of ±1%. The temperature control was carried out using a Stelar VTC-91 airflow heater 
equipped with a calibrated copper–constantan thermocouple (uncertainty of ±0.1 K). Additional data points 
in the range 20–70 MHz were obtained using a Stelar relaxometer equipped with a Bruker WP80 NMR 
electromagnet adapted to variable-field measurements (15–80 MHz proton Larmor frequency). Relaxometric 
HSA titrations were performed using the Stelar relaxometer at 0.47 T (20 MHz) and 25 °C in dilute aqueous 
solutions at neutral pH. 
17
O NMR spectra were recorded on a Bruker Avance III spectrometer (11.7 T) 
equipped with a 5 mm probe and a standard temperature control unit. Aqueous solutions of the complexes 
(ca. 6–10 mM) containing 2.0% of the 17O isotope (Cambridge Isotope) were used. The observed transverse 
relaxation rates were calculated from the signal width at half-height. 
 
 
 
 
X-ray crystallography 
Crystallographic data were collected at 100 K using a Bruker D8 Venture diffractometer equipped with a 
Photon 100 CMOS detector and Mo-Kα radiation (λ = 0.71073 Å) generated by an Incoatec high brilliance 
microfocus source equipped with Incoatec Helios multilayer optics. The software APEX3
42
 was used for 
collecting frames of data, indexing the reflections, and the determination of lattice parameters, SAINT
43
 for 
integration of the intensity of reflections, and SADABS
44
 for scaling and empirical absorption correction. 
The structure was solved by dual-space methods using the program SHELXT.
45
 All non-hydrogen atoms 
were refined with anisotropic thermal parameters by full-matrix least-squares calculations on F
2
 using the 
program SHELXL-2014.
46
 The Squeeze program
47
 was used to correct the reflection data for the diffuse 
scattering due to the disordered molecules present in the unit cell, which presumably correspond to a second 
K
+
 ion required for the electroneutrality and solvent molecules. Hydrogen atoms were inserted at calculated 
positions and constrained with isotropic thermal parameters. The atoms from the central carboxylate group in 
a DPAAA
3−
 moiety (C8, C9, O3 and O4) were disordered over two positions with equal occupation factors. 
CCDC 1518472 contains the supplementary crystallographic data for this paper. Crystal data and structure 
refinement details: formula: C32H36KMn2N6O18; MW: 941.65; crystal system: monoclinic; space 
group: P21/m; a = 10.4813(11) Å; b = 16.0788(17) Å; c = 14.7012(16) Å; β = 103.862(4)°; V = 2405.4(4) 
Å
3
; F(000) = 966; Z = 4; Dcalc. = 1.300 g cm
−3
; μ= 0.680 mm−1; θ range = 2.37–28.31°; Rint = 0.0425; 43 168 
measured reflections, of which 6180 were independent and 4909 were unique with I > 2σ(I). GOF on F2 = 
0.977; R1 = 0.0769; wR2 (all data) = 0.2411; the largest differences peak and hole: 1.823 and −1.453 e Å
−3
. 
Computational details 
Full geometry optimizations of the [Mn(DPAAA)(H2O)]
−
·2H2O and [Mn(DPAPhA)(H2O)2]·4H2O systems 
were performed in aqueous solution by DFT calculations at the TZVP/TPSSh
48,49
 level employing the 
Gaussian 09 package (Revision D.01).
50
 Solvent effects were included by using the polarizable continuum 
model (PCM), in which the solute cavity is built as an envelope of spheres centered on atoms or atomic 
groups with appropriate radii. In particular, we used the integral equation formalism (IEFPCM) variant as 
implemented in Gaussian 09.
51
 No symmetry constraints have been imposed during the optimizations. The 
stationary points found on the potential energy surfaces as a result of geometry optimizations were tested to 
represent energy minima rather than saddle points via frequency analysis. 
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HR-MS of the ligands and complexes, cmc determination, additional NMRD data and optimized Cartesian coordinates 
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